UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?

Urologic oncology, 2017, Vol.35 (1), p.34.e17-34.e25

2017

Volltextzugriff (PDF)

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses

Clinical nuclear medicine, 2017-04, Vol.42 (4), p.e188-e193

2017

Volltextzugriff (PDF)

Accuracy of urethral frozen section during radical cystectomy for bladder cancer

Urologic oncology, 2016-12, Vol.34 (12), p.532.e1-532.e6

2016

Volltextzugriff (PDF)

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Nature medicine, 2024-01, Vol.30 (1), p.218-228

2024

Volltextzugriff (PDF)

Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving Field

Academic pathology, 2021, Vol.8, p.23742895211037034-23742895211037034, Article 23742895211037034

2021

Volltextzugriff (PDF)

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

EJNMMI research, 2017-10, Vol.7 (1), p.80-80, Article 80

2017

Volltextzugriff (PDF)

Intravesical BCG Induces CD4 + T-Cell Expansion in an Immune Competent Model of Bladder Cancer

Cancer immunology research, 2017-07, Vol.5 (7), p.594-603

2017

Volltextzugriff (PDF)

Drug development risk and the cost of capital

Nature reviews. Drug discovery, 2012-05, Vol.11 (5), p.347-348

2012

Volltextzugriff (PDF)

222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 2), p.A1784-A1784

2023

Volltextzugriff (PDF)

Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer

European urology oncology, 2021-02, Vol.4 (1), p.117-120

2021

Volltextzugriff (PDF)

Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells

Human molecular genetics, 2010-02, Vol.19 (3), p.468-479

2010

Volltextzugriff (PDF)

DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation

American journal of physiology. Lung cellular and molecular physiology, 2004-02, Vol.286 (2), p.411-L419

2004

Volltextzugriff (PDF)

Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy

The Journal of urology, 2018-06, Vol.199 (6), p.1452-1458

2018

Volltextzugriff (PDF)

PD-L1 and PD-1 expression patterns in patients with NMIBC undergoing intravesical BCG

Urologic oncology, 2017-10, Vol.35 (10), p.613-614

2017

Volltextzugriff (PDF)

Combined next generation sequencing and flow cytometry analysis of an anti-PD-L1 partial responder over time: An exploration into mechanisms of PD-L1 activity and resistance

Urologic oncology, 2017-10, Vol.35 (10), p.608-609

2017

Volltextzugriff (PDF)

Correlation of 99m Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

EJNMMI research, 2017-10, Vol.7 (1), p.80

2017

Volltextzugriff (PDF)

Correlation of ^sup 99m^Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

EJNMMI research, 2017-10, Vol.7 (1), p.1

2017

Volltextzugriff (PDF)

DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation

American journal of physiology. Lung cellular and molecular physiology, 2004-02, Vol.30 (2), p.L411-L419

2004

Volltextzugriff (PDF)

ALG9 Mutation Carriers Develop Kidney and Liver Cysts

Journal of the American Society of Nephrology, 2019-11, Vol.30 (11), p.2091-2102

2019

Volltextzugriff (PDF)

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

The New England journal of medicine, 2017-07, Vol.377 (3), p.211-221

2017

Volltextzugriff (PDF)

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

Cancer informatics, 2022-01, Vol.21, p.11769351221136081-11769351221136081

2022

Volltextzugriff (PDF)

Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury

Laboratory investigation, 2011-08, Vol.91 (8), p.1170-1180

2011

Volltextzugriff (PDF)

Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence

Proceedings of the National Academy of Sciences - PNAS, 2019-10, Vol.116 (41), p.20482-20488

2019

Volltextzugriff (PDF)

Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016

European urology, 2021-02, Vol.79 (2), p.e58-e59

2021

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(53)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses

Accuracy of urethral frozen section during radical cystectomy for bladder cancer

Association between pathologic response and survival after neoadjuvant therapy in lung cancer

Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving Field

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

Intravesical BCG Induces CD4 + T-Cell Expansion in an Immune Competent Model of Bladder Cancer

Drug development risk and the cost of capital

Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer – Clinical Activity and Whole Transcriptome Analysis

222-N Analysis of pathologic features and efficacy outcomes with neoadjuvant nivolumab plus platinum-doublet chemotherapy for resectable non-small cell lung cancer in CheckMate 816

Combined Next-generation Sequencing and Flow Cytometry Analysis for an Anti-PD-L1 Partial Responder over Time: An Exploration of Mechanisms of PD-L1 Activity and Resistance in Bladder Cancer

Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells

DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation

Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy

PD-L1 and PD-1 expression patterns in patients with NMIBC undergoing intravesical BCG

Combined next generation sequencing and flow cytometry analysis of an anti-PD-L1 partial responder over time: An exploration into mechanisms of PD-L1 activity and resistance

Correlation of 99m Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

Correlation of ^sup 99m^Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression

DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation

ALG9 Mutation Carriers Develop Kidney and Liver Cysts

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

A Random Forest Genomic Classifier for Tumor Agnostic Prediction of Response to Anti-PD1 Immunotherapy

Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury

Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence

Aktive Filter

Suchergebnisse filtern